Drug Patent Expirations for the Week of March 31, 2024

EXSERVAN (riluzole) Aquestive Patent: 8,603,514 Expiration: Apr 3, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…

Source


Comments are closed.

Biotechblog